Compare SGMT & ODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SGMT | ODD |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 676.3M | 634.2M |
| IPO Year | 2021 | 2022 |
| Metric | SGMT | ODD |
|---|---|---|
| Price | $11.31 | $18.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 11 |
| Target Price | $26.13 | ★ $41.00 |
| AVG Volume (30 Days) | 899.9K | ★ 1.5M |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.92 |
| P/E Ratio | ★ N/A | $16.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.50 | $9.25 |
| 52 Week High | $11.45 | $63.56 |
| Indicator | SGMT | ODD |
|---|---|---|
| Relative Strength Index (RSI) | 65.15 | 62.24 |
| Support Level | $6.60 | $12.25 |
| Resistance Level | N/A | $20.16 |
| Average True Range (ATR) | 0.53 | 1.48 |
| MACD | -0.07 | 0.46 |
| Stochastic Oscillator | 91.61 | 74.62 |
Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.